MedTrace Logo

European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

NCT07668687 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-06-25

No results posted yet for this study

Summary

The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.

Conditions

  • Dissection of Thoracic Aorta
  • Dissection of Thoracic Descending Aorta
  • Aneurysm of Aorta, Thoracic
  • Penetrating Aortic Ulcers (PAUs)
  • Intramural Hematoma of the Thoracic Aorta
  • Ulcer-like Projection (ULP)

Interventions

DEVICE

Implantation with Castor™ stent graft

Treatment of subjects diagnosed with thoracic aortic pathologies using the Castor™ Branched Aortic Stent-Graft and Delivery System. Follow up as per institutional standard of care.

DEVICE

Implantation with Cratos™ stent graft

Treatment of subjects diagnosed with thoracic aortic pathologies using the Cratos™ Branched Aortic Stent-Graft and Delivery System. Follow up as per institutional standard of care.

Sponsors & Collaborators

  • Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Jing Wang · Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-12
Primary Completion
2028-10-31
Completion
2033-12-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07668687 on ClinicalTrials.gov